SiNON Therapeutics patented Carbon NanoDots (CNDsTM) are a drug delivery system with a novel release mechanism that allows for targeted treatment for brain tumors and other neurological diseases. At SiNON Therapeutics we have developed a tunable, platform delivery system that is engineered to encapsulate multiple different therapeutics, including biologics, up to 500kD, and deliver them across the blood-brain barrier (BBB) to treat neurological diseases. Because our CNDs will open only at the site of the tumor and not at healthy tissues, we can deliver higher doses with less overall toxicity for increased therapeutic efficacy. It has been shown that 30-40% of cancers metastasize to the brain yet due to the fact that only 2% of therapies can cross the BBB, the survival rate for patients with brain cancers is only 34%. Our mission is to give hope to thousands of patients suffering from brain tumors that presently have few options for life-saving treatments.
Company Details
- Founded
- -
- Address
- Boston , Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sinontx.com
- HQ
- Boston , MA
Sinon Nano Sciences Questions
Sinon Nano Sciences's website is http://www.sinontx.com
Sinon Nano Sciences's LinkedIn profile is https://www.linkedin.com/company/sinon-ns
Sinon Nano Sciences's industry is
Biotechnology Research
Sinon Nano Sciences's top competitors are
Envoya Inc.,
Innovo Bio,
Tatum Bioscience,
Centron Bio,
Arase Therapeutics,
Osteocure Therapeutics,
Paralog Therapeutics,
Veri Nano,
Genicity,
Tmab Therapeutics, Inc.
Sinon Nano Sciences's categories are Biotechnology Research
Sinon Nano Sciences's founding year is 2015
